New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
09:24 EDTAET, SQNMSequenom could benefit meaningfully from Aetna decision, says Oppenheimer
After Aetna (AET) recommended measuring cell-free fetal nucleic acids when testing for Down's syndrome in at-risk women, Oppenheimer thinks the recommendation suggests that Aetna is likely to pick up coverage of Sequenom's MaterniT21. The firm reiterates an Outperform rating on Sequenom.
News For SQNM;AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
10:00 EDTAETOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:31 EDTAETAetna upgraded to Buy from Neutral at BofA/Merrill
July 29, 2015
07:33 EDTAETHumana sees Aetna transaction closing in 2H16
Subscribe for More Information
July 27, 2015
13:24 EDTAETRegulators to consider 'too big to fail' in health insurance reviews, CTFN says
Subscribe for More Information
08:10 EDTAETLeerink sees at least 60% chance of Anthem, Cigna deal being approved
Subscribe for More Information
July 26, 2015
18:22 EDTAETMedia reports say Teva to buy Allergan unit as it looks beyond Mylan
Subscribe for More Information
July 22, 2015
08:43 EDTAETAetna positioned to report good Q2 results, says BMO Capital
Subscribe for More Information
July 16, 2015
19:17 EDTAETAffordable Care Act plan prices to increase 11.2% in 2016, WSJ says
State regulators will begin approving plan price increases for insurance plans purchased on Care Actís exchanges as early as this month, reports the Wall Street Journal. Nearly every state has plans with premiums increasing over 10%, with some as high as 30%-50%, the Journal adds. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use